Hara Tomoyo, Watanabe Takeshi, Yamagami Hiroki, Miyataka Kohsuke, Yasui Saya, Asai Takahito, Kaneko Yousuke, Mitsui Yukari, Masuda Shiho, Kurahashi Kiyoe, Otoda Toshiki, Yuasa Tomoyuki, Kuroda Akio, Endo Itsuro, Honda Soichi, Kondo Akira, Matsuhisa Munehide, Aihara Ken-Ichi
Department of Hematology, Endocrinology and Metabolism, Graduate School of Biomedical Sciences, Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.
Department of Preventive Medicine, Graduate School of Biomedical Sciences, Tokushima University, 3-18-15 Kuramoto-cho, Tokushima 770-8503, Japan.
Biomedicines. 2024 Aug 7;12(8):1789. doi: 10.3390/biomedicines12081789.
Although hyperglycemia and hypertension are well-known risk factors for glomerular injury in individuals with type 2 diabetes (T2D), specific risk factors for tubular injury remain unclear. We aimed to clarify the differences between risk factors for glomerular injury and risk factors for tubular injury in individuals with T2D. We categorized 1243 subjects into four groups based on urinary biomarkers, including the albumin-to-creatinine ratio (uACR) and L-type fatty acid-binding protein-to-creatinine ratio (uL-ABPCR) as a normal (N) group (uACR < 30 mg/gCr and uL-FABPCR < 5 μg/gCr; n = 637), a glomerular specific injury (G) group (uACR ≥ 30 mg/gCr and uL-FABPCR < 5 μg/gCr; n = 248), a tubular specific injury (T) group (uACR < 30 mg/gCr and uL-FABPCR ≥ 5 μg/gCr; n = 90), and a dual injury (D) group (uACR ≥ 30 mg/gCr and uL-FABPCR ≥ 5 μg/gCr; n = 268). Logistic regression analysis referencing the N group revealed that BMI, current smoking, and hypertension were risk factors for the G group, creatinine (Cr) and Fibrosis-4 (FIB-4) index were risk factors for the T group, and BMI, hypertension, HbA1c, Cr, and duration of diabetes were risk factors for the D group. While hypertension was a distinct specific risk factor for glomerular injury, the FIB-4 index was a specific contributor to the prevalence of tubular injury. On the other hand, the logistic regression analysis revealed that the hepatic steatosis index (HSI) did not show any significant association with the G group, T group, or D group. Taken together, the development of liver fibrosis rather than liver steatosis is an inherent threat relating to tubular injury in individuals with T2D.
虽然高血糖和高血压是2型糖尿病(T2D)患者肾小球损伤的众所周知的危险因素,但肾小管损伤的具体危险因素仍不清楚。我们旨在阐明T2D患者肾小球损伤危险因素与肾小管损伤危险因素之间的差异。我们根据尿生物标志物将1243名受试者分为四组,包括白蛋白与肌酐比值(uACR)和L型脂肪酸结合蛋白与肌酐比值(uL-ABPCR),分为正常(N)组(uACR<30mg/gCr且uL-FABPCR<5μg/gCr;n=637)、肾小球特异性损伤(G)组(uACR≥30mg/gCr且uL-FABPCR<5μg/gCr;n=248)、肾小管特异性损伤(T)组(uACR<30mg/gCr且uL-FABPCR≥5μg/gCr;n=90)和双重损伤(D)组(uACR≥30mg/gCr且uL-FABPCR≥5μg/gCr;n=268)。以N组为参照的逻辑回归分析显示,BMI、当前吸烟和高血压是G组的危险因素,肌酐(Cr)和纤维化-4(FIB-4)指数是T组的危险因素,BMI、高血压、糖化血红蛋白(HbA1c)、Cr和糖尿病病程是D组的危险因素。虽然高血压是肾小球损伤的一个明显的特异性危险因素,但FIB-4指数是肾小管损伤患病率的一个特定促成因素。另一方面,逻辑回归分析显示,肝脂肪变性指数(HSI)与G组、T组或D组均无显著关联。综上所述,肝纤维化而非肝脂肪变性的发展是T2D患者肾小管损伤的一个内在威胁。